EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection’s limited influence on overall survival, ATRX as molecular prognosticator

Alice Ryba iD, Zeynep Özdemir, Nitzan Nissimov, Lisa Hönikl, Nicolas Neidert, Martin Jakobs, Darius Kalasauskas, Aleksandrs Krigers, Claudius Thomé, Christian F Freyschlag, Florian Ringel, Andreas Unterberg und 12 weitere

Neuro-Oncology · 05.08.2024 · 26 (8) · 1479-1493

DOI: 10.1093/neuonc/noae061 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Neuro-Oncology, online erschienen am 20.03.2024. Verfasst von Alice Ryba und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Glioma, X-linked Nuclear Protein, Mutation, Brain Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

H3 K27M-mutated gliomas were first described as a new grade 4 entity in the 2016 World Health Organization classification. Current studies have focused on its typical appearance in children and young adults, increasing the need to better understand the prognostic factors and impact of surgery on adults. Here, we report a multicentric study of this entity in adults.

Methods

We included molecularly confirmed H3 K27M-mutated glioma cases in patients ≥ 18 years diagnosed between 2016 and 2022. Clinical, radiological, and surgical features were analyzed. Univariate and multivariate analyses were performed to identify prognostic factors.

Results

Among 70 patients with a mean age of 36.1 years, the median overall survival (OS) was 13.6 ± 14 months. Gross-total resection was achieved in 14.3% of patients, whereas 30% had a subtotal resection and 54.3% a biopsy. Tumors located in telencephalon/diencephalon/myelencephalon were associated with a poorer OS, while a location in the mesencephalon/metencephalon showed a significantly longer OS (8.7 vs. 25.0 months, P = .007). Preoperative Karnofsky-Performance Score (KPS) ≤ 80 showed a reduced OS (4.2 vs. 18 months, P = .02). Furthermore, ATRX loss, found in 25.7%, was independently associated with an increased OS (31 vs. 8.3 months, P = .0029). Notably, patients undergoing resection showed no survival benefit over biopsy (12 vs. 11 months, P = .4006).

Conclusions

The present study describes surgical features of H3 K27M-mutated glioma in adulthood in a large multicentric study. Our data reveal that ATRX status, location and KPS significantly impact OS in H3 K27M-mutated glioma. Importantly, our dataset indicates that resection does not offer a survival advantage over biopsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaX-linked Nuclear ProteinMutationBrain NeoplasmsHistonesHumansMaleFemaleAdultPrognosisMiddle AgedYoung AdultSurvival RateFollow-Up StudiesBiomarkers, TumorAgedAdolescentRetrospective Studies

Stichwörter der Autor:innen

H3 K27MH3F3AHIST1H3BHistone H3high-grade glioma

Substanzen

X-linked Nuclear ProteinATRX protein, humanHistonesBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurosurgery, Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Neurosurgery, University Hospital of Münster, Münster, Germany.
  • Department of Neurosurgery, Charité University Hospital Berlin, Berlin, Germany.
  • Department of Neurosurgery, Medical Center - University of Freiburg, Freiburg, Germany.
  • Department of Neurosurgery, Technical University Munich, Munich, Germany.
  • Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.

ORCID-Profile: Alice Ryba, Walter Stummer, Manfred Westphal, Ulrich Schüller, Malte Mohme

Zitieren

APA

Ryba, A., Özdemir, Z., Nissimov, N., Hönikl, L., Neidert, N., Jakobs, M., Kalasauskas, D., Krigers, A., Thomé, C., Freyschlag, C. F., Ringel, F., Unterberg, A., Dao Trong, P., Beck, J., Heiland, D. H., Meyer, B., Vajkoczy, P., Onken, J., Stummer, W., …, & Mohme, M. (2024). Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection’s limited influence on overall survival, ATRX as molecular prognosticator. Neuro-Oncology, 26(8), 1479-1493. https://doi.org/10.1093/neuonc/noae061

Vancouver

Ryba A, Özdemir Z, Nissimov N, Hönikl L, Neidert N, Jakobs M, et al. Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection’s limited influence on overall survival, ATRX as molecular prognosticator. Neuro-Oncology. 2024;26(8):1479-1493. doi:10.1093/neuonc/noae061

BibTeX
@article{Ryba2024,
  author = {Ryba, Alice and Özdemir, Zeynep and Nissimov, Nitzan and Hönikl, Lisa and Neidert, Nicolas and Jakobs, Martin and Kalasauskas, Darius and Krigers, Aleksandrs and Thomé, Claudius and Freyschlag, Christian F and Ringel, Florian and Unterberg, Andreas and Dao Trong, Philip and Beck, Jürgen and Heiland, Dieter Henrik and Meyer, Bernhard and Vajkoczy, Peter and Onken, Julia and Stummer, Walter and Suero Molina, Eric and Gempt, Jens and Westphal, Manfred and Schüller, Ulrich and Mohme, Malte},
  title = {Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection’s limited influence on overall survival, ATRX as molecular prognosticator},
  journal = {Neuro-Oncology},
  year = {2024},
  volume = {26},
  number = {8},
  pages = {1479--1493},
  doi = {10.1093/neuonc/noae061}
}
Kostenlos starten →